Skip to main content
Careers
Investors
Contact Us
Globe
Lilly
Menu
Menu
Menu closed
Lilly
Fermer
Close
Company
Expand mega menu
Expand submenu
Retour
Company
WHO WE ARE
Expand
About Lilly
Lilly in Canada
Key Facts
Recognitions
POLICIES & REPORTS
Expand
Public Policy
Science
Expand mega menu
Expand submenu
Retour
Science
DISCOVERY
Expand
Research and Scientific Discovery
Clinical Trials
Principles of Medical Research
Scientific Partnering
DISEASE AREAS
Expand
Diabetes
Cancer
Immunology
Pain
Neurodegeneration
Medicines
Expand mega menu
Expand submenu
Retour
Medicines
SAFETY
Expand
Patient Safety
Our Commitment to Patient Safety
Adverse Event Reporting
Anti-Counterfeiting
OUR MEDICINES
Expand
Current Medicines
Medicines Supply
Manufacturing & Quality
RESOURCES
Expand
Customer Response Centre
Impact
Expand mega menu
Expand submenu
Retour
Impact
EXTENDING OUR IMPACT
Expand
Grants, Donations and Funding
Fellowships
Therapeutic Area Grants
Charitable Donations
OPERATING RESPONSIBLY
Expand
Our Responsibility
Diversity & Inclusion
Ethics & Compliance
Environmental Sustainability
SOCIAL IMPACT
Expand
Our Approach
Global Health
Strengthening Communities
News
Expand mega menu
Expand submenu
Retour
News
STORIES
Expand
Caring
Science
Policy
All
PRESS RELEASES
Expand
Press Releases
MEDIA
Expand
Media Contacts
Globe
Loading...
Reveal available languages
English (Canada)
Français (Canada)
Careers
Investors
Contact Us
Globe
Author
Rhonda Pacheco
Rhonda Pacheco is the President and General Manager of Lilly Canada.
A Comment on PMPRB Regulations
Learn More
Left
Précédent
Prev
1
Suivant
Next
Right